October 11, 2012Transplant Trialsadmin Cytori Therapeutics announced the initiation of the FDA approved ATHENA clinical trial to investigate Cytori’s cell therapy in patients who suffer from a severe form of refractory heart failure due to chronic myocardial ischemia.
